Atopic Dermatitis: Investigational Compounds Study

We are evaluating new treatments for moderate to severe atopic dermatitis to see if they improve skin symptoms better than a placebo. The study also looks at the safety of these treatments.

3-6 monthsEfficacy phase (II)Investigational MedicinesInjectionAllergologyDermatology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Tacrolimus
Tacrolimus is a medicine that suppresses the immune system to help prevent organ transplant rejection and to treat severe eczema.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Pimecrolimus
Pimecrolimus is a topical substance that reduces skin inflammation and itching in people with eczema (atopic dermatitis).
Tacrolimus
Tacrolimus is a substance that suppresses the immune system to prevent organ transplant rejection and treat certain inflammatory conditions like severe eczema.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

GhZ339

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Adoport
Adport
Advagraf

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Fakultni Nemocnice Bulovka
2002 :Dermatovenerologicka klinika FNB a 2. LF UK
Dolní Chabry, Czechia
Fakultni Nemocnice Plzen
2003 :Dermatovenerologicka klinika, Edvarda Benese
Pilsen, Czechia
Fakultni Nemocnice Kralovske Vinohrady
2001:Dermatovenerologicka klinika 3.LF UK a FNKV
Prague, Czechia
Sponsor: Novartis Pharma AG
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.